{"SPADE_UN_14336": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_14336", "Peptide Name": "LP-64", "Source": "Synthetic construct", "Family": "Retroviridae", "Gene": "Not found", "Sequence": "KIEELLKKAEEQQKKNEEELKKLEX", "Sequence Length": 25, "UniProt Entry": ["http://www.uniprot.org/uniprot/P03377"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Antiviral"], "Target Organism": "[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=128±27 pM);HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=36±1 pM);HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=25±2 pM);T-20 sensitive HIV-1(NL4-3D36G):inhibition of virus infection in TZM-bl cells(IC50=0.04 nM);T-20 resistant HIV-1 NL4-3(WT,I37T,V38A,V38 M,Q40H,N43K,G36S/V38 M,I37T/N43K,V38A/N42T):inhibition of virus infection in TZM-bl cells(IC50=0.08-140.75 nM);HIV-2(ROD,ST):inhibition of virus infection in TZM-bl cells(IC50=0.23-0.75 nM);SIV(239,PBJ):inhibition of virus infection in TZM-bl cells(IC50=0.10-0.11 nM);HIV-1(3 A, 13 B, 7 C, 1 G, 1 A/C, 5 A/E, 6 B/C pseudovirus subtypes):inhibition of pseudovirus infection in TZM-bl cells(IC50=58 pM).", "Hemolytic Activity": "No hemolysis information or data found in the reference(s) presented in this entry", "Cytotoxicity": "No cytotoxicity information or data found in the reference(s) presented in this entry", "Binding Target": "membrane", "Linear/Cyclic": "Linear", "N-terminal Modification": "Acetylation", "C-terminal Modification": "Amidation", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C129H222N34O43", "Mass": 3066.73, "PI": 5.3, "Net Charge": -1, "Hydrophobicity": -1.772, "Half Life": "Mammalian:1.3 hourYeast:3 minE.coli:2 min", "Mechanism of action": "The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus–cell fusion.(By similar)", "Literature": [{"Title": "Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus.", "Pubmed ID": "30089693", "Reference": "J Virol. 2018 Sep 26;92(20)e01088-18.", "Author": "Chong H, Zhu Y, Yu D, He Y.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=30089693"}], "Frequent Amino Acids": "EKL", "Absent Amino Acids": "CDFGHMOPRSTUVWY", "Basic Residues": 7, "Acidic Residues": 8, "Hydrophobic Residues": 6, "Polar Residues": 11, "Positive Residues": 7, "Negative Residues": 8, "Similar Sequences": [{"SPADE_ID": "SPADE_UN_14327", "Similarity": 1.0, "Sequence": "WEQKIEELLKKAEEQQKKNEEELKK"}, {"SPADE_ID": "SPADE_UN_14328", "Similarity": 1.0, "Sequence": "WEQKIEELLKKAEEQQKKNEEELK"}, {"SPADE_ID": "SPADE_UN_14329", "Similarity": 1.0, "Sequence": "WEQKIEELLKKAEEQQKKNEEE"}]}}}